InnateDB Protein
|
IDBP-19304.6
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
SRD5A3
|
Protein Name
|
steroid 5 alpha-reductase 3
|
Synonyms
|
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000264228
|
InnateDB Gene
|
IDBG-19300 (SRD5A3)
|
Protein Structure
|
|
Function |
Plays a key role in early steps of protein N-linked glycosylation by being required for the conversion of polyprenol into dolichol. Dolichols are required for the synthesis of dolichol-linked monosaccharides and the oligosaccharide precursor used for N-glycosylation. Acts as a polyprenol reductase that promotes the reduction of the alpha-isoprene unit of polyprenols into dolichols in a NADP-dependent mechanism. Also able to convert testosterone (T) into 5-alpha-dihydrotestosterone (DHT). {ECO:0000269PubMed:17986282, ECO:0000269PubMed:20637498}.
|
Subcellular Localization |
Endoplasmic reticulum membrane {ECO:0000305PubMed:20637498}; Multi-pass membrane protein {ECO:0000305PubMed:20637498}.
|
Disease Associations |
Congenital disorder of glycosylation 1Q (CDG1Q) [MIM:612379]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269PubMed:20637498, ECO:0000269PubMed:22240719}. Note=The disease is caused by mutations affecting the gene represented in this entry.Kahrizi syndrome (KHRZ) [MIM:612713]: An autosomal recessive neurodevelopmental disorder characterized by mental retardation, cataracts, coloboma, kyphosis, and coarse facial features. {ECO:0000269PubMed:20700148}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Overexpressed in hormone-refractory prostate cancers (HRPC). Almost no or little expression in normal adult organs. {ECO:0000269PubMed:17986282}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
2
[view]
|
Protein-Protein |
2
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
Accession |
GO Term |
GO:0003865
|
3-oxo-5-alpha-steroid 4-dehydrogenase activity
|
GO:0016627
|
oxidoreductase activity, acting on the CH-CH group of donors
|
GO:0016628
|
oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor
|
GO:0047751
|
cholestenone 5-alpha-reductase activity
|
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR001104
3-oxo-5-alpha-steroid 4-dehydrogenase, C-terminal
|
PFAM |
PF02544
|
PRINTS |
|
PIRSF |
|
SMART |
|
TIGRFAMs |
|
Modification |
|
SwissProt |
Q9H8P0
|
PhosphoSite |
PhosphoSite-Q9H8P0
|
TrEMBL |
|
UniProt Splice Variant |
|
Entrez Gene |
79644
|
UniGene |
Hs.39311
|
RefSeq |
NP_078868
|
HUGO |
HGNC:25812
|
OMIM |
611715
|
CCDS |
CCDS3498
|
HPRD |
07825
|
IMGT |
|
EMBL |
AC064824
AK023414
BC002480
CH471057
CR457312
|
GenPept |
AAH02480
AAY40904
BAB14568
CAG33593
EAX05465
|
|
|